These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31847347)

  • 21. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
    Hessock M; Brewer T; Hutson S; Anderson J
    Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients.
    Ackerman MG; Shapiro PA; Coe A; Trivedi MS; Crew KD
    Breast J; 2017 Sep; 23(5):519-524. PubMed ID: 28323373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.
    Parkman AA; Foland J; Anderson B; Duquette D; Sobotka H; Lynn M; Nottingham S; Dotson WD; Kolor K; Cox SL
    J Genet Couns; 2015 Jun; 24(3):512-21. PubMed ID: 25242499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
    Machirori M; Patch C; Metcalfe A
    Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
    Joseph G; Beattie MS; Lee R; Braithwaite D; Wilcox C; Metrikin M; Lamvik K; Luce J
    J Genet Couns; 2010 Oct; 19(5):447-62. PubMed ID: 20490636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic counseling and testing for breast cancer risk in African Americans.
    Halbert CH
    LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington disease.
    Dorsey ER; Darwin KC; Nichols PE; Kwok JH; Bennet C; Rosenthal LS; Bombard Y; Shoulson I; Oster E
    Clin Genet; 2013 Sep; 84(3):251-7. PubMed ID: 23167775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Discrimination: The Genetic Information Nondiscrimination Act's Impact on Practice and Research.
    Underhill-Blazey M; Klehm MR
    Clin J Oncol Nurs; 2020 Apr; 24(2):135-137. PubMed ID: 32196007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
    Tercyak KP; Demarco TA; Mars BD; Peshkin BN
    Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine.
    Feldman EA
    J Gen Intern Med; 2012 Jun; 27(6):743-6. PubMed ID: 22314637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
    Katapodi MC; Munro ML; Pierce PF; Williams RA
    Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women's experience of telehealth cancer genetic counseling.
    Zilliacus EM; Meiser B; Lobb EA; Kirk J; Warwick L; Tucker K
    J Genet Couns; 2010 Oct; 19(5):463-72. PubMed ID: 20411313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act.
    Cragun D; Weidner A; Kechik J; Pal T
    Genet Test Mol Biomarkers; 2019 Feb; 23(2):75-83. PubMed ID: 30676117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
    Lehmann LS; Weeks JC; Klar N; Garber JE
    Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial impact of BRCA testing in young Black breast cancer survivors.
    Gonzalez BD; Hoogland AI; Kasting ML; Cragun D; Kim J; Ashing K; Holt CL; Hughes Halbert C; Pal T; Vadaparampil ST
    Psychooncology; 2018 Dec; 27(12):2778-2785. PubMed ID: 30207419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial.
    Halbert CH; Kessler L; Troxel AB; Stopfer JE; Domchek S
    Public Health Genomics; 2010; 13(7-8):440-8. PubMed ID: 20234119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Civilian and military genetics: nondiscrimination policy in a post-GINA world.
    Baruch S; Hudson K
    Am J Hum Genet; 2008 Oct; 83(4):435-44. PubMed ID: 18940308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.